Has anyone given a thought to what might happen here if the cell lines that ACTC is going to use for the IND is disallowed? I see where Dr. Lanza has some concern that the cell lines might not be accepted by the NIH. He even stated that he has put in a call to them. IMO he is just so smart that he will come up with what is acceptable to them but how much time would that take who can tell. For those here who would take this post as bashing please don't. I'm long 200 thousand shares and I am here for at least 3 to 5 years but when I read that Lanza is somewhat worried about these cell lines that they are going to use it made me stop and think hard about this predicament.
mclarence, glut is right, the NIH has nothting to do with whether the IND is accepted, that's the FDA's job. All the NIH can do is allow or reject federal funding for ACT's cell line. Of course Lanza would rather use federal money for these purposes and keep ACT's funds they would have used for other purposes. Nothing to worry about. GLTA!